TrialAngiogenesis2022

Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance).

Julia C F Quintanilha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.